News Article

The patchwork of regulation governing IVF treatment in Europe could be seen as a significant barrier to IVF providers looking to build pan-European brands, but these same variations are also driving a surge in cross-border treatment. Candesic partner, Marc Kitten, and analyst, Dr Nigel De Melo, discuss how consolidation in what remains a fragmented market could help drive safer and more accessible IVF services.